The Valley Desk

NCT03285178 · Interventional trial

A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)

Overall registry status Completed

Phase 2

Conditions Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov